181 related articles for article (PubMed ID: 12795445)
21. Do soy isoflavones lower cholesterol, inhibit atherosclerosis, and play a role in cancer prevention?
Arliss RM; Biermann CA
Holist Nurs Pract; 2002 Oct; 16(5):40-8. PubMed ID: 12465217
[TBL] [Abstract][Full Text] [Related]
22. Soyfoods, soybean isoflavones, and bone health: a brief overview.
Messina M; Messina V
J Ren Nutr; 2000 Apr; 10(2):63-8. PubMed ID: 10757817
[TBL] [Abstract][Full Text] [Related]
23. Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer.
Ahn-Jarvis JH; Clinton SK; Grainger EM; Riedl KM; Schwartz SJ; Lee ML; Cruz-Cano R; Young GS; Lesinski GB; Vodovotz Y
Cancer Prev Res (Phila); 2015 Nov; 8(11):1045-54. PubMed ID: 26276749
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer: The main risk and protective factors-Epigenetic modifications.
Adjakly M; Ngollo M; Dagdemir A; Judes G; Pajon A; Karsli-Ceppioglu S; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
Ann Endocrinol (Paris); 2015 Feb; 76(1):25-41. PubMed ID: 25592466
[TBL] [Abstract][Full Text] [Related]
25. Soy and isoflavone consumption in relation to prostate cancer risk in China.
Lee MM; Gomez SL; Chang JS; Wey M; Wang RT; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):665-8. PubMed ID: 12869409
[TBL] [Abstract][Full Text] [Related]
26. Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats.
Pollard M; Luckert PH
Nutr Cancer; 1997; 28(1):41-5. PubMed ID: 9200149
[TBL] [Abstract][Full Text] [Related]
27. Regulation of male sex hormone levels by soy isoflavones in rats.
Yi MA; Son HM; Lee JS; Kwon CS; Lim JK; Yeo YK; Park YS; Kim JS
Nutr Cancer; 2002; 42(2):206-10. PubMed ID: 12416261
[TBL] [Abstract][Full Text] [Related]
28. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men.
Kurahashi N; Iwasaki M; Sasazuki S; Otani T; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):538-45. PubMed ID: 17337648
[TBL] [Abstract][Full Text] [Related]
29. Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men.
Maskarinec G; Morimoto Y; Hebshi S; Sharma S; Franke AA; Stanczyk FZ
Eur J Clin Nutr; 2006 Dec; 60(12):1423-9. PubMed ID: 16775579
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
Fischer L; Mahoney C; Jeffcoat AR; Koch MA; Thomas BE; Valentine JL; Stinchcombe T; Boan J; Crowell JA; Zeisel SH
Nutr Cancer; 2004; 48(2):160-70. PubMed ID: 15231450
[TBL] [Abstract][Full Text] [Related]
31. Soy for breast cancer survivors: a critical review of the literature.
Messina MJ; Loprinzi CL
J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
[TBL] [Abstract][Full Text] [Related]
32. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States).
Jacobsen BK; Knutsen SF; Fraser GE
Cancer Causes Control; 1998 Dec; 9(6):553-7. PubMed ID: 10189040
[TBL] [Abstract][Full Text] [Related]
33. [Prostate cancer prevention].
Miyanaga N; Akaza H
Gan To Kagaku Ryoho; 2015 May; 42(5):538-43. PubMed ID: 25981647
[TBL] [Abstract][Full Text] [Related]
34. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis.
Sirtori CR
Drug Saf; 2001; 24(9):665-82. PubMed ID: 11522120
[TBL] [Abstract][Full Text] [Related]
35. Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor.
McCormick DL; Johnson WD; Bosland MC; Lubet RA; Steele VE
Nutr Cancer; 2007; 57(2):184-93. PubMed ID: 17571952
[TBL] [Abstract][Full Text] [Related]
36. Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits.
Yamakoshi J; Piskula MK; Izumi T; Tobe K; Saito M; Kataoka S; Obata A; Kikuchi M
J Nutr; 2000 Aug; 130(8):1887-93. PubMed ID: 10917898
[TBL] [Abstract][Full Text] [Related]
37. Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial.
Dewell A; Weidner G; Sumner MD; Barnard RJ; Marlin RO; Daubenmier JJ; Chi C; Carroll PR; Ornish D
Nutr Cancer; 2007; 58(1):35-42. PubMed ID: 17571965
[TBL] [Abstract][Full Text] [Related]
38. Isoflavones and the prevention and treatment of prostate disease: is there a role?
Gaynor ML
Cleve Clin J Med; 2003 Mar; 70(3):203-4, 206, 208-9 passim. PubMed ID: 12678210
[TBL] [Abstract][Full Text] [Related]
39. Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy.
Sahin I; Bilir B; Ali S; Sahin K; Kucuk O
Integr Cancer Ther; 2019; 18():1534735419835310. PubMed ID: 30897972
[TBL] [Abstract][Full Text] [Related]
40. Genistein alters growth but is not toxic to the rat prostate.
Fritz WA; Eltoum IE; Cotroneo MS; Lamartiniere CA
J Nutr; 2002 Oct; 132(10):3007-11. PubMed ID: 12368387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
